Evidence map›Paper›PMID 34331021›Full record

ArticleBone marrow transplantation2021

Newly proposed threshold and validation of white blood cell count at diagnosis for Philadelphia chromosome-positive acute lymphoblastic leukemia: risk assessment of relapse in patients with negative minimal residual disease at transplantation-a report from the Adult Acute Lymphoblastic Leukemia Working Group of the JSTCT.

Yu Akahoshi, Yasuyuki Arai, Satoshi Nishiwaki, Takayoshi Tachibana, Akihito Shinohara, Noriko Doki, Naoyuki Uchida, Masatsugu Tanaka, Yoshinobu Kanda, Souichi Shiratori and 7 more

Abstract read
PubMed Publisher
In one paragraph

Article in Bone marrow transplantation, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.6field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 6 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 11 institutions in 1 country.

Yu AkahoshiDivision of Hematology, Jichi Medical University Saitama Medical Center, Saitama, Japan. akahoshiu@gmail.com.ORCID http://orcid.org/0000-0001-6825-9340
Yasuyuki AraiDepartment of Hematology and Oncology, Graduate School of Medicine, Kyoto University, Kyoto, Japan.ORCID http://orcid.org/0000-0002-9662-5093
Satoshi NishiwakiDepartment of Advanced Medicine, Nagoya University Hospital, Nagoya, Japan.ORCID http://orcid.org/0000-0002-6430-8958
Takayoshi TachibanaDepartment of Hematology, Kanagawa Cancer Center, Yokohama, Japan.ORCID http://orcid.org/0000-0002-7780-4459
Akihito ShinoharaDepartment of Hematology, Tokyo Women's Medical University, Tokyo, Japan.ORCID http://orcid.org/0000-0002-5530-6133
Noriko DokiHematology Division, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, Tokyo, Japan.
Naoyuki UchidaDepartment of Hematology, Federation of National Public Service Personnel Mutual Aid Associations Toranomon Hospital, Tokyo, Japan.ORCID http://orcid.org/0000-0001-5952-5926
Masatsugu TanakaDepartment of Hematology, Kanagawa Cancer Center, Yokohama, Japan.
Yoshinobu KandaDivision of Hematology, Jichi Medical University Saitama Medical Center, Saitama, Japan.ORCID http://orcid.org/0000-0002-4866-9307
Souichi ShiratoriDepartment of Hematology, Hokkaido University Faculty of Medicine, Sapporo, Japan.ORCID http://orcid.org/0000-0002-5528-7112
Yukiyasu OzawaDepartment of Hematology, Japanese Red Cross Nagoya First Hospital, Nagoya, Japan.
Katsuhiro ShonoDepartment of Hematology, Chiba Aoba Municipal Hospital, Chiba, Japan.ORCID http://orcid.org/0000-0002-5163-0163
Yuta KatayamaDepartment of Hematology, Hiroshima Red Cross Hospital and Atomic Bomb Survivors Hospital, Hiroshima, Japan.ORCID http://orcid.org/0000-0001-5054-9104
Junji TanakaDepartment of Hematology, Tokyo Women's Medical University, Tokyo, Japan.
Takahiro FukudaDivision of Hematopoietic Stem Cell Transplantation, National Cancer Center Hospital, Tokyo, Japan.
Yoshiko AtsutaJapanese Data Center for Hematopoietic Cell Transplantation, Nagoya, Japan.ORCID http://orcid.org/0000-0003-4404-2870
Shinichi KakoDivision of Hematology, Jichi Medical University Saitama Medical Center, Saitama, Japan.ORCID http://orcid.org/0000-0002-2635-3395
Jichi Medical University · JPKanagawa Prefectural Hospital Organization · JPTokyo Women's Medical University · JPChiba Aoba Municipal Hospital · JPHiroshima Red Cross Hospital & Atomic-bomb Survivors Hospital · JPHokkaido University · JPKyoto University · JPNagoya University Hospital · JPThe Japanese Data Center for Hematopoietic Cell Transplantation · JPTokyo Metropolitan Komagome Hospital · JPToranomon Hospital · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

White blood cell count (WBC) at diagnosis is the conventional prognostic factor in Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph

Indexed as

Hematopoietic Stem Cell TransplantationPrecursor Cell Lymphoblastic Leukemia-LymphomaHumansLeukocyte CountNeoplasm, ResidualPhiladelphia ChromosomePrognosisRecurrenceRisk Assessment

Identifiers

PMID34331021
OpenAlexW3183186103

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.